In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines

Abstract

There is a pressing requirement to define a hazard identification and risk management strategy for nanomaterials due to the rapid growth in the nanotechnology industry and their promise of life-style revolutions through the development of wide-ranging nano-containing consumer products. Consequently, a battery of well defined and appropriate in vitro assays… (More)
DOI: 10.1016/j.mrgentox.2011.09.013

Topics

Cite this paper

@inproceedings{Doak2012InVG, title={In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines}, author={Shareen Heather Doak and Bella B Manshian and G. Jenkins and Nitya Singh}, booktitle={Mutation research}, year={2012} }